Aytu BioPharma Inc. (AYTU)
1.01
-0.01 (-0.98%)
At close: Apr 17, 2025, 3:37 PM
1.01
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT
Aytu BioPharma Revenue Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Consumer Health Revenue | 11.85M | 3.97M | 8.93M | 8.25M |
| Consumer Health Revenue Growth | +198.66% | -55.56% | +8.22% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2024 | Jun 30, 2022 |
|---|---|---|
| Non-Us Revenue | 91K | 2.06M |
| Non-Us Revenue Growth | -95.59% | n/a |
| United States Revenue | 80.91M | 94.61M |
| United States Revenue Growth | -14.48% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.72M | 10.78M | 11.09M | 11.99M | 12.02M | 14.38M | 14.1M | 19.98M | 18.58M | 17.42M | 17.4M | 17.36M | 17.61M | 17.51M | 20.73M | 12.85M | 12.85M | 11.49M | 13.64M | 9.5M | 6.52M | 5.15M | 4.9M | 5.38M | 5.14M | 3.83M | 3.92M | 4.64M | 4.55M | 4.62M | 27.82K | 4.42M | 3.69M | 5.76M | 3.15M | 2.25M | 1.77M | 1.71M | 1.4M | 1.09M |
| Selling, General, and Administrative Revenue Growth | -9.86% | -2.74% | -7.53% | -0.20% | -16.43% | +2.01% | -29.46% | +7.55% | +6.62% | +0.16% | +0.22% | -1.45% | +0.57% | -15.53% | +61.32% | -0.01% | +11.86% | -15.75% | +43.54% | +45.81% | +26.61% | +5.10% | -8.92% | +4.64% | +34.14% | -2.37% | -15.42% | +1.87% | -1.41% | +16499.57% | -99.37% | +19.71% | -35.84% | +82.46% | +40.52% | +26.55% | +3.79% | +22.47% | +28.28% | n/a |
| Research and Development Revenue | 522K | 426K | 1.04M | 619K | 524K | 604K | 465K | 856K | 1.71M | 1.06M | 3.7M | 3.73M | 4.92M | 2.1M | 4.76M | 389.26K | 286.57K | 182.87K | 1.5M | 78.5K | 66.67K | 78.02K | 175.26K | 108.9K | 149.03K | 155.88K | 189.99K | 114.14K | -277.49K | 140.95K | 185.33K | 571.01K | 311.45K | 280.02K | 2.87M | 1.19M | 1.36M | 903.87K | 849.23K | 742.18K |
| Research and Development Revenue Growth | +22.54% | -59.20% | +68.66% | +18.13% | -13.25% | +29.89% | -45.68% | -49.94% | +60.71% | -71.22% | -0.78% | -24.27% | +134.73% | -56.00% | +1123.85% | +35.83% | +56.71% | -87.79% | +1808.51% | +17.74% | -14.54% | -55.48% | +60.94% | -26.93% | -4.39% | -17.95% | +66.45% | -141.13% | -296.86% | -23.94% | -67.54% | +83.34% | +11.23% | -90.24% | +140.65% | -12.15% | +50.07% | +6.43% | +14.42% | n/a |
| Sales and Marketing Revenue | 5.27M | 5.66M | 6.41M | 6.55M | 6.58M | 7.42M | 7.98M | 12.8M | 10.56M | 10.1M | 10.01M | 9.74M | 9.66M | 9.3M | 12.18M | 6.6M | 5.71M | 5.83M | 11.4M | n/a | n/a | n/a | -352K | 7K | 91K | 254K | n/a | n/a | n/a | n/a | -3.71M | n/a | n/a | n/a | 282 | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -6.84% | -11.73% | -2.11% | -0.41% | -11.40% | -7.02% | -37.66% | +21.25% | +4.53% | +0.89% | +2.77% | +0.86% | +3.90% | -23.67% | +84.63% | +15.64% | -2.08% | -48.91% | n/a | n/a | n/a | -100.00% | -5128.57% | -92.31% | -64.17% | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a |